Edgewood Management Portfolio holdings
AUM
$31.5B
This Quarter Return
+18.59%
1 Year Return
+19.46%
3 Year Return
+128.01%
5 Year Return
+144.65%
10 Year Return
+626.11%
AUM
$31.2B
AUM Growth
+$31.2B
(+11%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-4.55%
Top 10 Holdings %
Top 10 Hldgs %
55.24%
Holding
86
New
3
Increased
14
Reduced
29
Closed
3
Top Buys
| 1 |
Airbnb
ABNB
|
$735M |
| 2 |
Eli Lilly
LLY
|
$729M |
| 3 |
Blackstone
BX
|
$339M |
| 4 |
Microsoft
MSFT
|
$180M |
| 5 |
lululemon athletica
LULU
|
$159M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$935M |
| 2 |
Amazon
AMZN
|
$849M |
| 3 |
CME Group
CME
|
$776M |
| 4 |
Illumina
ILMN
|
$241M |
| 5 |
Nike
NKE
|
$188M |
Sector Composition
| 1 | Technology | 33.05% |
| 2 | Healthcare | 19.71% |
| 3 | Financials | 15.46% |
| 4 | Consumer Discretionary | 15.12% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.4M | ﹤0.01% |
3
| – | – |
|
52
Bank of New York Mellon
BK
$74.5B
| $1.35M | ﹤0.01% |
29,704
| – | – |
|
53
Prothena Corp
PRTA
$441M
| $1.17M | ﹤0.01% |
24,060
| – | – |
|
54
Exxon Mobil
XOM
$487B
| $1.03M | ﹤0.01% |
9,436
-38
| -0.4% | -$4.17K |
|
|
LAC
55
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $979K | ﹤0.01% |
45,000
| – | – |
|
56
Palantir
PLTR
$372B
| $845K | ﹤0.01% |
100,000
| – | – |
|
57
Merck
MRK
$210B
| $832K | ﹤0.01% |
7,818
| – | – |
|
58
Royalty Pharma
RPRX
$15.6B
| $829K | ﹤0.01% |
23,000
| – | – |
|
59
Zoetis
ZTS
$69.3B
| $765K | ﹤0.01% |
4,596
+154
| +3% | +$25.6K |
|
60
Agios Pharmaceuticals
AGIO
$2.19B
| $689K | ﹤0.01% |
30,000
| – | – |
|
|
ETG
61
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.59B
| $678K | ﹤0.01% |
42,000
| – | – |
|
62
iShares Russell 1000 Growth ETF
IWF
$116B
| $673K | ﹤0.01% |
2,755
-611,051
| -100% | -$149M |
|
63
AT&T
T
$209B
| $664K | ﹤0.01% |
34,500
+5,000
| +17% | +$96.3K |
|
64
Freeport-McMoran
FCX
$63.7B
| $586K | ﹤0.01% |
14,319
| – | – |
|
65
Vodafone
VOD
$28.8B
| $584K | ﹤0.01% |
52,886
| – | – |
|
66
Snap
SNAP
$12.1B
| $583K | ﹤0.01% |
52,000
+3,000
| +6% | +$33.6K |
|
67
Seres Therapeutics
MCRB
$166M
| $567K | ﹤0.01% |
100,000
| – | – |
|
68
Duke Energy
DUK
$95.3B
| $527K | ﹤0.01% |
5,468
| – | – |
|
69
Arrowhead Research
ARWR
$3.05B
| $483K | ﹤0.01% |
19,000
| – | – |
|
70
BlackRock New York Municipal Income Trust
BNY
$231M
| $468K | ﹤0.01% |
45,000
| – | – |
|
71
Ginkgo Bioworks
DNA
$750M
| $333K | ﹤0.01% |
250,000
+50,000
| +25% | +$66.5K |
|
72
Verizon
VZ
$186B
| $330K | ﹤0.01% |
8,478
| – | – |
|
73
Procter & Gamble
PG
$368B
| $327K | ﹤0.01% |
2,200
| – | – |
|
74
Warner Bros
WBD
$28.8B
| $313K | ﹤0.01% |
20,725
| – | – |
|
75
Charles Schwab
SCHW
$174B
| $281K | ﹤0.01% |
5,360
-2,600
| -33% | -$136K |
|